 |
Code of Federal Regulations (Last Updated: November 8, 2024) |
 |
Title 21 - Food and Drugs |
|
Chapter I—Food and Drug Administration, Department of Health and Human Services |
|
SubChapter E—Animal Drugs, Feeds, and Related Products |
|
Part 520 - Oral Dosage Form New Animal Drugs |
§ 520.1780 - Pimobendan tablets.
-
§ 520.1780 Pimobendan tablets.
(a) Specifications. Each chewable tablet contains 1.25, 2.5, 5, or 10 milligrams (mg) pimobendan.
(b) SponsorSponsors. See NoNos. 000010 and 069043 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs —
(1) Amount. Administer orally at a total daily dose of 0.23 mg per pound (0.5 mg per kilogram) body weight, using a suitable combination of whole or half tablets. The total daily dose should be divided into two portions administered approximately 12 hours apart.
(2) Indications for use. For the management of the signs of mild, moderate, or severe congestive heart failure in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM); for use with concurrent therapy for congestive heart failure (e.g., furosemide, etc.) as appropriate on a case-by-case basis.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[72 FR 27733, May 17, 2007, as amended at 79 FR 18158, Apr. 1, 2014; 87 FR 10968, Feb. 28, 2022; 89 FR 42357, May 15, 2024; 89 FR 85426, Oct. 28, 2024]